DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Online

Drug Development Phase 2

Learn the factors that drive the design and conduct of phase 2 clinical trials, as well as the activities and functional areas that contribute to a successful phase 2 program.

Authors

Stephen V.  O'Quinn, PharmD

Stephen V. O'Quinn, PharmD

President, Perissos, Inc., United States

Stephen O’Quinn, PharmD, is the founder and President of Perissos, Inc which specializes in helping clients drive business results through insight-driven marketing and medical strategies. Stephen spent over 20 years with GlaxoSmithKline in senior leadership roles in both marketing and medical functions-- from medicines development through commercial product launch and lifecycle management. Stephen's marketing leadership roles included serving as Senior Director for 12 brands across five different therapeutic areas. Stephen holds a Doctor of Pharmacy degree, with highest honors, from the University of North Carolina at Chapel Hill.

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。